Log in
Enquire now
‌

US Patent 9034324 Anti-BCMA antibodies

Patent 9034324 was granted and assigned to Biogen on May, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Biogen
Biogen
0
Date Filed
March 10, 2010
0
Date of Patent
May 19, 2015
0
Patent Application Number
13255610
0
Patent Citations Received
‌
US Patent 11873336 Heavy chain antibodies binding to CD22
0
‌
US Patent 11905326 Multispecific heavy chain antibodies binding to CD22 and CD3
0
‌
US Patent 11884720 Antibody constructs for MSLN and CD3
0
‌
US Patent 11965025 Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules
0
‌
US Patent 12109234 Anti-BCMA CAR T cell compositions
0
‌
US Patent 12006369 BCMA chimeric antigen receptors
0
‌
US Patent 11970540 Anti-BCMA heavy chain-only antibodies
0
Patent Inventor Names
Susan L. Kalled
0
Yen-Ming Hsu
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9034324
0
Patent Primary Examiner
‌
Laura B Goddard
0

Find more entities like US Patent 9034324 Anti-BCMA antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.